L.A. Commander, A.E. Seif, I.G. Insogna, S.R. Rheingold. Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma. „Br J Haematol”, May 2010. DOI: 10.1111/j.1365-2141.2010.08236.x. PMID: 20528871.
A. Fullmer, S. O’Brien, H. Kantarjian, E. Jabbour. Novel therapies for relapsed acute lymphoblastic leukemia. „Curr Hematol Malig Rep”. 4 (3), s. 148–156, Jul 2009. DOI: 10.1007/s11899-009-0021-6. PMID: 20425428.
D.I. Marks, E.M. Paietta, A.V. Moorman, S.M. Richards i inni. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). „Blood”. 114 (25), s. 5136–5145, Dec 2009. DOI: 10.1182/blood-2009-08-231217. PMID: 19828704.
L.A. Commander, A.E. Seif, I.G. Insogna, S.R. Rheingold. Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma. „Br J Haematol”, May 2010. DOI: 10.1111/j.1365-2141.2010.08236.x. PMID: 20528871.
A. Fullmer, S. O’Brien, H. Kantarjian, E. Jabbour. Novel therapies for relapsed acute lymphoblastic leukemia. „Curr Hematol Malig Rep”. 4 (3), s. 148–156, Jul 2009. DOI: 10.1007/s11899-009-0021-6. PMID: 20425428.
D.I. Marks, E.M. Paietta, A.V. Moorman, S.M. Richards i inni. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). „Blood”. 114 (25), s. 5136–5145, Dec 2009. DOI: 10.1182/blood-2009-08-231217. PMID: 19828704.